Jul 16, 2024
Eleva's bryotechnology revolutionizes biologics manufacturing. Björn talks about the critical roles of perseverance and innovation in the biotech industry.
Oct 17, 2024
...is dedicated to pediatric case reports and Eleva’s Factor H (CPV-104) study program.
Oct 17, 2024
...is dedicated to pediatric case reports and Eleva’s Factor H (CPV-104) study program.
May 13, 2024
Data demonstrates the therapeutic potential of Factor H (CPV-104) as complement modulator and delivered preclinical proof-of-concept in C3G.
Next Page